Anna Mazzeo

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Guido Cavaletti, David R. Cornblath, Ingemar S. J. Merkies et al. · Annals of Oncology · 2012 · 284 citations · Full text

Health Sciences, Peripheral Nerve Injury, Pain Medicine +10

Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy

Maria C. Monici, M. Aguennouz, Anna Mazzeo et al. · Neurology · 2003 · 172 citations

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

Paola Alberti, Emanuela Rossi, David R. Cornblath et al. · Annals of Oncology · 2013 · 171 citations · Full text

Neurotoxicology, Pharmacology, Neuropathic Pain +4

Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP

Andrea Cortese, Raffaella Lombardi, Chiara Briani et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 170 citations · Full text

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5